Skip to content

Clinical trials

Phase 3 Heart Failure trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 3 Country / region: United States Clear all

129 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20025
20036
20043
200510
20066
20076
20087
20093
20101
20113
20125
20134
20145
20152
20162
20177
20188
20193
20206
20212
20232
202410
20256
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed82
Terminated21
Recruiting17
Active, not recruiting3
Unknown status2
Not yet recruiting1
Suspended1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Duke University8
Novartis Pharmaceuticals8
Boehringer Ingelheim7
AstraZeneca5
Bayer3
Colorado Prevention Center3
Columbia University3
GE Healthcare3
Janssen Research & Development, LLC3
Mayo Clinic3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure129
Cardiovascular Diseases14
Heart Diseases11
Myocardial Infarction8
Hypertension7
Hypertension, Pulmonary6
Atrial Fibrillation4
Cardiomyopathies4
Coronary Artery Disease4
Heart Failure, Diastolic4

Trials

Showing 1 to 25 of 129. Each trial links to its page on Pharma Observatory.

29 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.